Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

NSE/BIOCON stock hub

NSE/BIOCON has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/BIOCONis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

615.6B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/BIOCON

In the news

Latest news · NSE/BIOCON

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E110.1

P25 24.9P50 32.4P75 45.7

Trailing P/E79.9

P25 24.8P50 35.9P75 56.9

ROEn/a

P25 6.3P50 13.6P75 18.1

ROIC3.6

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/BIOCON market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

200

Groups with data

Currency

INR

Showing 200 of 200 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	16,420
Employees Change	105%
Employees Change Percent	0.64
Enterprise value	INR 782.5B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Biotechnology
Isin	INE376G01013
Last refreshed	2026-05-10
Market cap	INR 615.6B
Price	INR 379
Price currency	INR
Rev Per Employee	10,248,112.06x
Sector	Healthcare
Sic	2836
Symbol	nse/BIOCON
Website	https://www.biocon.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.98%
EV Earnings	129.5x
EV/EBIT	46.1x
EV/EBITDA	22.96x
EV/Sales	4.65x
Forward P/E	110.13x
P/B ratio	1.86x
P/E ratio	79.91x
P/S ratio	3.66x
PE Ratio10 Y	55.09x
PE Ratio3 Y	58.75x
PE Ratio5 Y	61.21x
PEG ratio	2.24x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	10.09%
EBITDA Margin	19.9%
Gross margin	60.87%
Gross Profit	INR 102.4B
Gross Profit Growth	13.52%
Gross Profit Growth Q	15.09%
Gross Profit Growth3 Y	18.91%
Gross Profit Growth5 Y	17.13%
Net Income	INR 6B
Net Income Growth	-24.88%
Net Income Growth Q	472.91%
Net Income Growth Years	0%
Net Income Growth3 Y	15.9%
Net Income Growth5 Y	-0.21%
Pretax Margin	4.08%
Profit Margin	3.59%
Profit Per Employee	INR 367,966
Profitable Years	23
Roa5y	2.76
Roe5y	6.82
ROIC	3.58
Roic5y	5.68

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	14.19%
Cagr15y	13.85%
Cagr1y	9.45%
Cagr20y	12.82%
Cagr3y	16.29%
Cagr5y	0.07%
Div CAGR10	0%
Div CAGR3	-30.66%
Div CAGR5	0%
EPS Growth	-29.06
EPS Growth Q	409.5
EPS Growth Years	0
EPS Growth3 Y	13.67
EPS Growth5 Y	-1.38
Revenue Growth	13.99x
Revenue Growth Q	9.2x
Revenue Growth Quarters	5x
Revenue Growth Years	11x
Revenue Growth3 Y	19.71x
Revenue Growth5 Y	19.55x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 61B
Debt	INR 165.4B
Debt EBITDA	INR 4.85
Debt Equity	INR 0.5
Equity	INR 330.6B
Interest Coverage	1.77
Net Cash	INR -104.3B
Net Cash By Market Cap	INR -16.95
Net Debt EBITDA	INR 3.12
Net Debt Equity	INR 0.32
Tangible Book Value	INR -9.8B
Tangible Book Value Per Share	INR -7.62
WACC	5.46

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-5.94%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	INR 0.5
Dividend Years	4
Dividend Yield	0.13%
Ex Div Date	2026-07-03
Last Dividend	INR 0.5
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	276.95%
1Y total return	9.44%
200-day SMA	374.2
3Y total return	57.27%
50-day SMA	370.9
50-day SMA vs 200-day SMA	50under200
5Y total return	0.37%
All Time High	487.8
All Time High Change	-22.36%
All Time High Date	2020-12-23
All Time Low	14.17
All Time Low Change	2,573.11%
All Time Low Date	2008-12-02
ATR	10.55
Beta	0.23
Beta1y	0.23
Beta2y	0.35
Ch YTD	-3.86
High	396.4
High52	425
High52 Date	2025-11-18
High52ch	-10.88%
Low	377.3
Low52	317.9
Low52 Date	2025-05-12
Low52ch	19.13%
Ma50ch	2.11%
Price vs 200-day SMA	1.21%
RSI	61.81
RSI Monthly	55.46
RSI Weekly	52.87
Sharpe ratio	0.65x
Sortino ratio	1.14
Total Return	-5.81%
Tr YTD	-3.86
Tr15y	599.97%
Tr1m	11.37%
Tr1w	5.02%
Tr3m	3.64%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 17B
Operating Income Growth	21.26
Operating Income Growth Q	-2.51
Operating Income Growth3 Y	13.96
Operating Income Growth5 Y	14.93
Operating margin	10.09

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	708,708,358%
Shares Insiders	46%
Shares Institutions	23.65%
Shares Out	1,618,370,751
Shares Qo Q	3.89%
Shares Yo Y	5.94%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	3,073,718.9x
Bv Per Share	207.9
Ch10y	270.9
Ch15y	532
Ch1m	11.37
Ch1w	5.02
Ch1y	9.29
Ch20y	853.5
Ch3m	3.64
Ch3y	55.94
Ch5y	-0.64
Ch6m	-0.45
Change	-0.93%
Change From Open	-0.08
Close	382.3
Days Gap	-0.85
Depreciation Amortization	16,506,250,000
Dollar Volume	2,150,949,348.8
Earnings Date	2026-05-07
EBIT	INR 17B
EBITDA	INR 33.5B
EPS	INR 4.76
F Score	1
Fiscal Year End	March
Founded	1,978
Graham Number	149.23519
Graham Upside	-60.59
Income Tax	INR 576M
Is Primary Listing	1
Last Earnings Date	2026-05-07
Last Report Date	2025-12-31
Last Split Date	2019-06-12
Last Split Type	Forward
Lynch Fair Value	INR 23.8
Lynch Upside	-93.71
Ma150	375.9
Ma150ch	0.74%
Ma20	360.2
Ma20ch	5.14%
Next Earnings Date	2026-05-14
Open	379
Payment Date	2025-08-22
Position In Range	7.57
Price Date	2026-05-08
Price EBITDA	INR 18.39
Relative Volume	1.91x
Revenue	168,274,000,000x
Tax By Revenue	0.34x
Tax Rate	8.38%
Tr20y	1,016.33%
Tr6m	-0.45%
Volume	5,679,824

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

NSE/BIOCON dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.1%

$0.50 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

0.0%

0 consecutive years of growth

Total shareholder yield

-5.8%

Next ex-dividend date: 2026-07-03

Performance

NSE/BIOCON stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/BIOCON?

Insider, institutional, and short-interest positioning.

Institutional ownership

+23.7%

Share of float held by funds and institutions

Insider ownership

+46.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+5.9%

Negative means the company is buying back shares.

Technical

NSE/BIOCON momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

61.8

Neutral momentum band

Price vs 200-day MA

+1.2%

50/200-day relationship not available

Beta (5Y)

0.23

Less volatile than the market

Sharpe ratio

0.65

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/BIOCON

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/BIOCON stock rating?

nse/BIOCON is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/BIOCON analysis?

The full report lives at /stocks/nse/BIOCON/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/BIOCON?

The latest report frames nse/BIOCON around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/BIOCON page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.